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Abstract
Objectives To determine whether clinical, laboratory or
Magnetic Resonance Imaging (MRI) measures differentiate
Juvenile Idiopathic Arthritis (JIA) from other forms of active
childhood arthritis.
Materials and methods We prospectively collected data of 80
treatment-naïve patients clinically suspected of JIAwith active
non-infectious arthritis of (at least) one knee for <12 months
duration. Upon presentation patients underwent clinical and
laboratory assessments and contrast-enhanced MRI. MRI was
not used as a diagnostic criterion.
Results Forty-four (55 %) patients were clinically diagnosed
with JIA, whereas in 36 (45 %) patients the diagnosis of JIA
was discarded on clinical or laboratory findings. MRI-based
synovitis was present in 27 (61.4 %) JIA patients and in 7
(19.4 %) non-JIA patients (P<0.001).
Five factors (male gender, physician’s global assessment of
overall disease activity, joints with limited range of motion,
HLA-B27, MRI-based synovitis) were associated with the
onset of JIA. In multivariate analysis MRI-based synovitis
proved to be independently associated with JIA (OR 6.58,
95 % CI 2.36-18.33). In patients with MRI-based synovitis,
the RR of having JIAwas 3.16 (95 % CI 1.6-6.4).
Conclusions The presence of MRI-based synovitis is associ-
ated with the clinical onset of JIA. Physical examination could
be supported by MRI, particularly to contribute in the early
differentiation of different forms of non-infectious childhood
arthritis.
Key points
• Juvenile Idiopathic Arthritis (JIA) is a diagnosis of
exclusion.
• Differentiating JIA and other forms of childhood arthritis
can be difficult.
• MRI-techniques have substantially improved evaluation of
joint abnormalities in JIA patients.
•MRI-based synovitis is significantly associated with the clin-
ical onset of JIA.
• MRI could support physical examination in the early differ-
entiation of childhood arthritis.
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Introduction
Juvenile idiopathic arthritis (JIA) is an umbrella term for all
forms of arthritis of unknown aetiology and pathophysiology
that begin before the age of 16 and persists for more than six
weeks [1]. The term JIA includes seven well-defined disease
categories, marked by distinct presentations, clinical features,
and, in some cases, genetic backgrounds. Before JIA can be
diagnosed, other known causes of arthritis in children have to
be excluded. Even though JIA is a group of well-defined dis-
ease categories [1], it is sometimes hard to differentiate be-
tween JIA and other forms of childhood arthritis. Since JIA
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needs another treatment strategy than - for example - reactive
arthritis or transient non-infectious arthritis [2], it is essential
to discriminate the different forms of arthritis in the early
phase. Moreover, early therapeutic intervention improves
long-term outcome in JIA patients [3, 4]. A delay in treatment
of JIA could lead to irreversible damage of the joint. Thus, a
swift diagnosis and early treatment of JIA leads to a decrease
in disease burden. Currently, no evidence exists for diagnostic
tools that differentiate early JIA from other forms of non-
infectious arthritis.
In JIA, synovial proliferation and infiltration by inflamma-
tory cells occurs in affected joints, resulting in increased se-
cretion of synovial fluid and synovial hypertrophy. Persistent
synovitis may eventually lead to articular cartilage lesions and
bone erosions that are responsible for disability and reduced
quality of life in JIA [5–8]. Within the past decade, the use of
magnetic resonance imaging (MRI) and advances in MRI
techniques have substantially improved the evaluation of joint
abnormalities in JIA patients [9, 10]. Currently, MRI is con-
sidered to be the most suitable imaging technique in this re-
spect [10]. Although MRI has previously been shown to be
more sensitive than physical examination in the detection of
active joint inflammation [11–15], its ability to distinguish
different forms of childhood arthritis has been questioned
[16, 17]. Therefore, the aim of our study was to determine
whether clinical, laboratory or MRI measures were able to
differentiate JIA patients from other forms of childhood arthri-




We prospectively included 80 consecutive patients in two ter-
tiary paediatric rheumatology centres (Academic Medical
Center and Reade, both Amsterdam, the Netherlands) over a
three-year period (January 2009 - December 2011). At the
time of presentation, all patients had extensive clinical and
laboratory assessments, followed by contrast-enhanced MRI.
Inclusion criteria were clinically active arthritis suspected for
JIA, involvement of at least one knee (as the most common
clinically affected joint in JIA [18]), and disease duration of
more than six weeks but less than 12 months. Exclusion
criteria consisted of a history of intra-articular corticosteroid
injection within the last six months, the need for anaesthesia
during MRI, general contraindications for MRI, and arthritis
based on an infection (streptococcal disease, Lyme disease or
parvo infections), and <8 years of age (following the advice of
the local medical ethical board). This study was performed in
accordance with the Declaration of Helsinki and the local
medical ethical regulations. Written informed consent was ob-
tained from at least one parent of each child.
Clinical and laboratory assessments
Physical examination was performed by the same paediatric
rheumatologists for each patient (JMvdB, DSM, MAJvR,
TWK, and KD) during the research period. Clinical assess-
ment included a 67-joint count defining the presence of swell-
ing, pain on motion/tenderness, and limited range of motion.
A physician’s global assessment of overall disease activity, a
patient’s global assessment of overall well-being and an as-
sessment of patient’s pain were all measured on a 100 mm
visual analogue scale (VAS). Functional ability was evaluated
by the Dutch version of the childhood health assessment ques-
tionnaire (CHAQ) [19, 20]. Laboratory tests included the
erythrocyte sedimentation rate (ESR), the C-reactive protein
(CRP) level, and the presence of antinuclear antibody (ANA),
human leukocyte antigen (HLA)-B27, and IgM rheumatoid
factor (RF).
MRI protocol and image analysis
Contrast-enhanced MR images were obtained using 1.0-T
magnet (Panorama HFO, Philips Medical Systems, Best, the
Netherlands). To increase feasibility and patient comfort, we
used an open-bore magnet [14]. The unsedated children were
placed in the supine position with the knee joint centrally in
the magnetic field using a dedicated knee coil. MRI of the
clinically most affected knee (target joint) was performed.
MRI sequences included sagittal T2-weighted fat saturated
images (TR 2800-4500 ms; TE 50 ms; slice thickness 4 mm;
field of view 150×150 mm; matrix 300×242), coronal T2-
weighted fat saturated images (TR 2800-4500 ms; TE 50 ms;
slice thickness 4 mm; field of view 150×150 mm; matrix
300×247), axial T2-weighted fat saturated images (TR
2800-4500 ms; TE 50 ms; slice thickness 4 mm; field of view
150×150 mm; matrix 300×270), sagittal T1-weighted images
obtained before and after intravenous contrast injection (TR
450-650 ms; TE 10 ms; slice thickness 4 mm; field of view
150×150 mm; matrix 300×248, 0.1 mmol per kilogram of
body weight gadobutrol (Bayer healthcare, Berlin, Germany)
with an injection rate of 3 ml/sec by using an automatic injec-
tion device (Medrad, Warrendale, PA, USA)), and axial T1-
weighted fat saturated images obtained after intravenous con-
trast injection (TR 400-750 ms; TE 10 ms; slice thickness
4 mm; field of view 150×150 mm; matrix 272×192).
The image sets were scored by a radiology expert blinded
to the clinical data (RH, five years of experience in musculo-
skeletal radiology). The MRI data sets were scored in accor-
dance with the semi-quantitative Juvenile Arthritis MRI
Scoring (JAMRIS) system. This scoring method has been
validated and described before in detail [21]. Briefly, synovial
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hypertrophy was scored when thickness of the contrast-
enhanced synovial membrane was ≥2 mm. Bone marrow
changes suggestive of bone marrow oedema were defined as
lesions within the trabecular bone, with ill-defined margins
and high signal intensity on T2-weighted fat-saturated images,
and low signal intensity on T1-weighted images. A cartilage
lesion was defined as superficial loss and/or thinning, or deep
loss to subchondral bone. Bone erosions were defined as
sharply marginated bone lesions, with correct juxta-articular
localization, and visible in two planes with a cortical break in
at least one plane. On T1-weighted images, there is a loss of
normal low signal intensity of cortical bone and loss of normal
high signal intensity of trabecular bone. Synovial hypertrophy
was scored at six locations: patellofemoral, suprapatellar re-
cesses, infrapatellar fat pad, adjacent to the anterior- and pos-
terior cruciate ligaments, medial posterior-condylar, and later-
al posterior-condylar. Bone marrow changes, cartilage lesions,
and bone erosions were scored at eight locations: lateral pa-
tella, medial patella, medial femur condylar, lateral femur con-
dylar, medial weight-bearing region of the femur, lateral
weight-bearing region of the femur, medial tibia plateau, and
lateral tibia plateau.
Study outcome
The primary study outcome was a clinical diagnosis of JIA.
According to the ILAR criteria, JIA was defined as clinical
arthritis of unknown aetiology and pathophysiology that be-
gins before the age of 16 years and persists for at least six
weeks [1]. Clinical arthritis was defined as joints with swelling
as well as joints with pain on motion and/or limited range of
motion [1]. According to the ILAR criteria, the eventual con-
firmation of a definite diagnosis of JIA was made – by the
same paediatric rheumatologist for each patient – after a min-
imal follow-up period of six months [1]. JIA is a clinical
diagnosis and the diagnosis was made by the paediatric rheu-
matologist according to the abovementioned definitions.
Solely clinical and laboratory assessments were used by the
treating physician to diagnose JIA and differentiate JIA from
other forms of childhood arthritis. Thus, the findings on MRI
were not used in the diagnosis of JIA.
The reading radiologist was blinded for the clinical diag-
nosis. However, in the event that MRI findings indicated a
diagnosis other than JIA (e.g., traumatic or orthopaedic pa-
thology), the treatment strategy was adjusted by the treating
physician following feedback from the radiologist.
Statistics
All data were analysed by using IBM SPSS version 19.0
(SPSS, Chicago, USA). Descriptive statistics were reported
in terms of percentages, means, medians, inter-quartile ranges,
and standard deviations. The Mann-Whitney U test and
Fisher’s exact test were used to analyse differences between
groups/scores. Factors potentially associated with the study
outcome in univariate analysis (P value less than 0.2) were
included in amultivariate model. Backward stepwise selection
was performed. A two-tailed P value of less than 0.05 was
considered statistically significant. Results were presented as
odds ratios (OR) with 95 % confidence intervals (95 % CI).
Additionally, the negative predictive value (NPV), the positive




In this prospective study, MRI datasets of 80 treatment naïve
patients (60 % female patients, mean age 12.5 years (SD 3.5))
with clinically active arthritis of the knee suspected of JIA
were collected. The baseline characteristics are depicted in
Table 1. A definite clinical diagnosis of JIA was made in 44
(55 %) patients according to the ILAR criteria. As a conse-
quence, 36 (45 %), patients had no JIA. Of these non-JIA
patients, 16 (44.4 %) were diagnosed with reactive knee
Table 1 Patient characteristicsa
Clinical feature Suspected JIA
n=80
No. (%) of female patients 48 (60.0 %)
Age at study visit, mean years (SD) 12.5 (3.5)
Disease duration at study visit, years 0.4 (0.3 – 0.7)
Physician’s global assessment of overall
disease activityb
30 (16 – 41)
Patient’s global assessment of overall
well-beingb
49 (20 – 62)
Patient’s pain assessmentb 59 (35 – 74)
C-HAQ scorec 1.125 (0.625 – 1.750)
No. of active joints 5 (1 – 4)
No. of joints with limited range of motion 1 (0 – 2)
Laboratory measure
Erythrocyte sedimentation rate, mm/hour 5 (2 – 8)
C-reactive protein level, mg/l 1 (0 – 1)
No. (%) of ANA-positive patientsd 25 (31.3 %)
No. (%) of HLA-B27-positive patientse 18 (22.5 %)
No. (%) of RF-positive patientsf 0 (0.0 %)
a Except where otherwise indicated, values are median (inter-quartile
range)
b Measured on a 0-100 mm visual analogue scale (0=best, 100=worst)
c Units; 0.000=best, 3.000=worst
d ANA=antinuclear antibody
e HLA-B27=human leukocyte antigen (HLA)-B27
f RF=IgM rheumatoid factor
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symptoms (seven reactive knee symptoms based on hy-
permobility, four due to relative overuse, three with
patello-femoral maltraction, one with large cystic lesion,
and one with a retro-patellar cartilage defect); three
(8.3 %) with osteochondritis dissecans, seven (19.4 %)
patients with another immunologic disorder (four with
systemic lupus erythematosus, one with scleroderma,
one with juvenile dermatomysositis, and one with an un-
classified immunologic disorder); two (5.6 %) with tran-
sient arthritis, and eight (22.2 %) patients were diagnosed
with anatomical, traumatic, or other non-rheumatologic
ailments (two with a meniscal tear, one with a discoid
meniscus, one with a large anterior cruciate ligament gan-
glion, and four with a chronic pain syndrome).
Concerning the JIA patients, frequencies of JIA subtypes
were as follows: eight (18.2 %) persistent oligoarthritis,
five (11.4 %) extended oligoarthritis, 14 (31.8 %)
polyarthritis, four (9.1 %) psoriatic arthritis, ten
(22.7 %) enthesitis-related arthritis, and three (6.8 %) un-
differentiated JIA. Of all patients, 42 (52.5 %) patients
received no medication, while 38 (47.5 %) patients used
NSAIDs only.
Clinical findings
No significant differences were found between JIA and non-
JIA patients regarding age (12.7 years vs. 12.3 years, P=
0.961), physicians’ global assessment of overall disease activ-
ity (34 vs. 26, P=0.053), patient’s pain assessment (62 vs. 52,
P=0.402), patient’s global assessment of overall well-being
(50 vs. 49, P=0.615), CHAQ scores (1.250 vs. 0.625, P=
0.193), the number of actively inflamed joints (2 vs. 2, P=
0.123), and the number of joints with limited range of motion
(1 vs. 0, P=0.069, respectively).
Laboratory findings
ESR did not differ between JIA and non-JIA patients (5 vs. 5,
P=0.157). There was no difference in ANA-positivity be-
tween the two groups (29.5 % vs. 33.3 %, P=0.810). No
RF-positive patients were identified in this group; therefore,
this parameter was omitted for further analysis.
In contrast, a significant difference between both groups
was observed regarding the median CRP level (5.2 vs. 1.4,
P=0.046) and the number of HLA-B27-positive patients
(31.8 % vs. 11.1 %, P=0.033, respectively).
MRI findings
Synovial hypertrophy as a major MRI feature of synovitis
was present in 27 (61.4 %) of the JIA patients, whereas
synovial hypertrophy was present in seven (19.4 %) of the
non-JIA patients (P<0.001) (Figs. 1 and 2). In case of
non-JIA patients, their disease activity scores, joint
scores, CHAQ scores, and blood parameters of inflamma-
tion (ESR and CRP) at baseline were all comparable be-
tween the non-JIA patients with or without MRI-based
synovial hypertrophy. Of these seven non-JIA patients
with synovial hypertrophy, three patients were diagnosed
with reactive symptoms with an anatomical substrate (one
based on discoid meniscus, one based on a meniscal tear,
and one based on a large anterior cruciate ligament gan-
glion), two with osteochondritis dissecans, one patient
with systemic lupus erythematosus, and one patient with
transient arthritis of undetermined aetiology.
No significant differences were observed between pa-
tients with an eventual diagnosis of JIA and the non-JIA
patients regarding the presence of bone marrow changes
(suggestive of oedema), cartilage lesions, or bone ero-
sions. Cartilage lesions were present in three out of 36
(8.3 %) of the non-JIA patients, including one with an
abnormality interpreted as a bone erosion. Of these three
patients, two were diagnosed by MRI with osteochondritis
dissecans (Fig. 3), and one with reactive knee symptoms
based on a meniscal tear. Two out of these three patients
had accompanying MRI-based synovial hypertrophy.
Additionally, no differences were observed between the
different subtypes of JIA regarding the presence of MRI-
based synovial hypertrophy or bone marrow changes sugges-
tive of bone marrow oedema.
Fig. 1 Eventual JIA patient with synovitis. a. sagittal fat saturated T2-
weighted image, b. sagittal T1-weighted image with the injection of Gd,
and an axial T1-weighted fat saturatedMR image after the injection of Gd
obtained in a 15-year-old boy with suspected JIA show a thickened,
irregular synovial membrane (arrows)
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Univariate analysis
Univariate analysis identified five factors that were potentially
associated with the onset of JIA (Table 2). These were male
gender (OR 3.29, 95 % CI 1.26-8.57), the physician’s global
assessment of overall disease activity (OR 1.03, 95%CI 1.00-
1.05), number of joints with limited range of motion (OR
1.20, 95 % CI 0.96-1.50), presence of HLA-B27 (OR 3.73,
95 % CI 1.10-12.62), and the presence of MRI-based synovi-
tis (OR 6.58, 95 % CI 2.36-18.33).
Multivariate analysis
Multivariate analysis with backward selection showed that only
the presence ofMRI-based synovitis proved to be independent-
ly and significantly associated with the onset of JIA. In patients
with the presence ofMRI-based synovitis at baseline, the RR of
having JIAwas 3.16 (95 % CI 1.56-6.39), the positive predic-
tive value 0.79, and the negative predictive value 0.63.
Discussion
Our study evaluated whether clinical, laboratory, orMRI mea-
sures can differentiate JIAwith active childhood arthritis from
other causes of non-infectious arthritis in a group of patients
with clinical signs of early arthritis. For the first time we show
that of the various parameters tested, only the presence of
MRI-based synovitis was found independently and signifi-
cantly associated with JIA at presentation.
As early therapeutic intervention improves long-term out-
come in JIA patients, objective and accurate measures in the
evaluation of disease activity are essential [3, 4]. Currently,
MRI is considered to be the most sensitive imaging modality
for the evaluation of early inflammatory changes in JIA, in-
cluding synovitis as the most critical hallmark of disease ac-
tivity in JIA, as well as the late changes of cartilage and bone
[10, 22, 23]. Our study implies that current measures for the
categorization of different forms of childhood arthritis, which
largely rely on clinical symptoms, physical joint examination,
and laboratory results, are insufficient in the early discrimina-
tion of different forms of childhood arthritis. In the current
study, we showed that MRI might be helpful in aiding the
differentiation JIA from other causes of knee pain/symptoms
in clinically suspected non-infectious arthritis. Our results are
in line with another study assessing differences in MRI find-
ings between subgroups of recent-onset childhood arthritis
[24], and supports the notion that physical examination could
be supported by more sensitive tools such as MRI.
Currently, MRI is the state-of-the-art imaging modality
able to visualize bone marrow changes suggestive for bone
marrow oedema. In rheumatoid arthritis (RA) destruction of
bone is frequently preceded by bone marrow oedema. In ad-
dition, the presence of bone marrow oedema upon MRI is a
key predictor of early erosive joint damage in RA [25, 26]. In
paediatric JIA patients, the value of bone marrow changes is
unclear. As growing joints change anatomically, it is hard to
distinguish pathologic bone marrow oedema from bone mar-
row changes due to normal maturation. Moreover, the preva-
lence of signal changes suggestive of bone marrow oedema in
wrists and knees of healthy children is high [27, 28]. In the
current study, the presence ofMRI-based bonemarrow chang-
es had no discriminating or prognostic value and was equally
present in both JIA patients and non-JIA patients (27.3 % and
33.3 %, respectively). The clinical relevance of the presence
Fig. 2 Non-JIA patient with reactive knee symptoms based on a large
cystic lesion. a. sagittal fat saturated T2-weighted image, b. sagittal T1-
weighted image with the injection of Gd, and an axial T1-weighted fat
saturated MR image after the injection of Gd obtained in a 10-year-old
boy show a large cystic lesion (arrows) without signs of synovial
hypertrophy
Fig. 3 Osteochondritis dissecans. a. sagittal T1-weighted post-contrast,
and b. sagittal fat saturated T2-weighted images obtained in a 15-year-old
girl show a lesion in the distal femoral condyle, with marked bone
marrow oedema (black arrows) and signal intensity changes of the adja-
cent cartilage (white arrows)
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of bone marrow changes in paediatric JIA patients remains,
therefore, unclear. This MRI feature seems to be unrelated to
JIA disease activity but is suspected to be part of the joint
development or the patient’s biomechanics instead.
Although MRI is the preferred imaging modality in JIA
given its superior imaging quality, it has some practical limi-
tations in daily practice. These include the necessity for seda-
tion in very young children, the need of an intravenous con-
trast agent for the detection of synovial disease, and the limit-
ed number of joints that can be evaluated during one imaging
session because of time constraints [10, 29]. Despite these
practical limitations, the results of our current study imply that
contrast-enhanced MRI is not only of value in the scope of
research and clinical trials in JIA, but has important diagnostic
value in daily clinical practice. Among many clinical, physi-
cal, laboratory findings taken into consideration, only the
presence of MRI-based synovitis was independently and sig-
nificantly associated with the onset of JIA.
Currently, we focused on MRI as an outcome measure in
JIA. However, likewise the use of ultrasound (US) is being
used to an increasing extent for the evaluation of disease status
in JIA patients. Improvements in resolution have enhanced the
performance of US. It is a safe, painless, and patient-friendly
procedure without the use of ionizing radiation. Despite the
advantages of US in paediatric JIA patients, it lacks standard-
ization and information on its reliability. Moreover. the re-
sponsiveness of US to assess changes over time is unknown
and US is not able to access all joints (including the knee as
the most common clinically involved joint in JIA) [18, 30].
MRI is a unique method for the early distinction between
JIA and other forms of childhood arthritis, and may facilitate a
correct initiation and tailoring of the therapeutic strategy, giv-
en that physical examination by expert physicians seems not
sufficient to guide the expert rheumatologist to an early defi-
nite diagnosis of JIA. Moreover, in the non-JIA group, signs
of synovial hypertrophy upon MRI evaluation led to an alter-
native diagnosis that helped to avoid the improper use of anti-
rheumatic drugs and in some cases expedited orthopaedic
intervention.
The main strengths of our study consist of the prospective
study design and the relatively large number of patients that
were included. This is the first study assessing the predictive
value of clinical, laboratory, and MRI measures to diagnose
the onset of JIA in a patient group with similar clinical
Table 2 Factors associated with the onset of JIA: univariate analysis*
Univariate analysis
Study group 95 % CI
Clinical feature JIA No JIA OR Lower Upper P value
Age Mean (SD) 12.6 (3.4) 12.3 (3.4) 1.03 0.91 1.18 0.611
Gender (male) No. (%) 32 (53.3) 9 (25) 3.29 1.26 8.57 0.015
Physician’s global assessment of overall disease activitya Median (IQR) 34 (16-55) 26 (14-34) 1.03 1.00 1.05 0.042
No. of active joints Median (IQR) 2 (2-6) 2 (1-4) 1.05 0.94 1.17 0.415
No. of joints with limited range of motion Median (IQR) 1 (0-2) 0 (0-2) 1.20 0.96 1.50 0.103
Patient’s global assessment of overall well-beinga Median (IQR) 50 (25-65) 49 (19-57) 1.01 0.99 1.03 0.634
Patient’s pain assessmenta Median (IQR) 62 (35-77) 52 (35-71) 1.01 0.99 1.3 0.505
C-HAQ scoreb Median (IQR) 1.250 (0.625-1.750) 0.625 (0.625-1.500) 1.67 0.76 3.69 0.201
Laboratory measure
Erythrocyte sedimentation rate, mm/hour Median (IQR) 5 (3-9) 5 (2-7) 1.04 0.99 1.09 0.272
C-reactive protein level, mg/l Median (IQR) 1 (1-3) 1 (0-1) 1.09 0.92 1.30 0.321
Antinuclear antibody positive No. (%) 13 (29.5) 12 (33.3) 0.84 0.32 2.17 0.716
HLA-B27 positivec No. (%) 14 (31.8) 4 (11.1) 3.73 1.10 12.62 0.034
MRI feature
Synovitis score of ≥1 No. (%) 27 (61.4) 7 (19.4) 6.58 2.36 18.33 0.000
Bone marrow oedema score of ≥1 No. (%) 12 (27.3) 12 (33.3) 0.75 0.29 1.96 0.557
Cartilage lesion score of ≥1 No. (%) 4 (9.1) 3 (8.3) 1.10 0.23 5.27 0.905
Bone erosion score of ≥1 No. (%) 1 (2.3) 1 (2.8) 0.81 0.05 13.9 0.86
* Factors highlighted in bold are potentially associated with the onset of JIA (P value less than 0.2)
a Measured on a 0-100 mm visual analogue scale (0=best, 100=worst)
b Units; 0.000=best, 3.000=worst
c HLA-B27=human leukocyte antigen (HLA)-B27
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symptoms of early arthritis by clinical experts in the field. A
limitation of the study is that our results may not be directly
applicable to other cohorts. Moreover, the studied population
may be subjected to selection bias, as the demographic and
clinical findings of the enrolled patients (high mean age at
disease onset, high percentage of male, and high prevalence
of enthesitis related arthritis) is not a proper reflection of a real
JIA population at disease onset. Besides, no differences where
observed in ANA positivity between JIA and non-JIA pa-
tients, which further underpins this statement. Therefore, our
results need external validation in an independent cohort to
test the strength and applicability of our findings.
In summary, we conclude that the presence of MRI-based
synovitis is significantly associated with the onset of JIA at the
early presentation. MRI may support physical examination,
particularly in the early differentiation of JIA from other forms
of early non-infectious childhood arthritis and (unsuspected)
orthopaedic pathology.
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